IHWM
DGX icon

Iron Horse Wealth Management’s Quest Diagnostics DGX Stock Holding History

Iron Horse Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$3.05K Hold
17
– – ﹤0.01% 430
2025
Q1 		$2.88K Buy
+17
New +$2.79K ﹤0.01% 424

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Iron Horse Wealth Management's DGX Position: Q2 2025 in Review

Iron Horse Wealth Management held its Quest Diagnostics (DGX) position steady in Q2 2025 at 17 shares worth $3.05K. The position accounts for ﹤0.01% of the portfolio, ranked #430.

Iron Horse Wealth Management first reported a position in DGX in Q1 2025 and has held it in 2 quarters since. 990 funds tracked by Wall St. Rank hold DGX as of Q2 2025.

  • Iron Horse Wealth Management held 17 shares of Quest Diagnostics worth $3.05K as of Q2 2025.
  • Iron Horse Wealth Management left its Quest Diagnostics share count unchanged in Q2 2025.
  • Quest Diagnostics made up ﹤0.01% of Iron Horse Wealth Management's portfolio in Q2 2025, its #430 holding.
  • Iron Horse Wealth Management first reported a position in Quest Diagnostics in Q1 2025 and has held it in 2 quarters since.
  • 990 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.

Based on Iron Horse Wealth Management's 13F filing for Q2 2025, filed 22 Jul 2025.